MAHEC
Open

Stimulant Use Disorders 201: What Healthcare Providers CAN Offer

Course # 69735
Stimulant Use Disorders 201: What Healthcare Providers CAN Offer

Location

Online Course
MAHEC
Asheville, NC 28803

Dates & Times

Oct 31, 2022 8:00 AM – Sep 30, 2023 8:00 AM

Contact

Do you have event related questions or need help with registration?

Register now for this online self-guided course.
AVAILABLE IMMEDIATELY!

Despite the prevalence and impact of stimulant use in the United States, current pharmacological treatment options have limited supporting evidence and none are FDA-approved for the treatment of stimulant use disorder. This program, developed by an addiction psychiatrist and family medicine physician, will review current treatment options and their supporting literature with an emphasis on what therapies to offer and which populations are most likely to benefit. This program is designed to build upon knowledge previously presented in Stimulant Use Disorder 101 and will address topics such as the provision of pre-exposure prophylaxis (PrEP) for harm reduction, the management of patients who use stimulants who may also have ADHD and the diagnosis and treatment of stimulant-induced psychosis. Participants will hear from a peer-led panel as they discuss their role, how they engage with patients with stimulant use disorder, utilizing harm reduction, and the ways that providers can best address their patients' needs.

MAHEC engages in evaluation activities to better understand the impact of our programs. By registering for this course, you agree that we may use your personal information in evaluative research regarding this program. Any reports published will be de-identified and reported in aggregate format.

Approximate time to complete the course: 120 minutes
Learner content includes: PowerPoint, Peer Video and Posttest
Participants will have 45 days from the date of their registration to complete this course. After that date, course materials will no longer be accessible.


With the Support from

NCDHHS


Vaya Health

Audience

This program is recommended for medical providers, nurses and other healthcare professionals, behavioral health professionals (including substance abuse counselors, social workers, and psychologists), law enforcement, human services, community health workers, and others interested in this subject.

Objectives

check Review the role of pharmacologic treatment of psychostimulant use disorder
check Outline an approach to the patient with stimulant use disorder and a history of ADHD
check Describe diagnosis and treatment of stimulant-induced psychosis
check Utilize experience from peer support specialists to identify additional ways to support patients in recovery

Fees

Cancellation Policy

Registration Fee

$25.00

Speakers

Mike Almand
Samantha C. Bradley, NCCPSS
Danny Hawkins, CPSS
Dustin Patil, MD
Jan Westphal, MD

Additional Resources

Cancellation Policy

MAHEC has a pay-up-front policy for all CE programs. The only exceptions will be for pre-approved programs where an individual payment plan is appropriate. Registrations received without accompanying payment will not be processed and participants who have not paid the course fee will not be admitted into the program.

Unless otherwise noted in course materials, the following cancellation policy applies to all programs:

  • Cancellations must be in writing (fax, email, or mail).
  • Cancellations received more than 2 weeks prior to the event will receive 100% refund.
  • Cancellations received between two weeks and two full business days prior to the first day of the event are refunded at 70% of the registration fee subject to a minimum $25 cancellation fee.
  • No refunds or credits will be given for cancellations received less than two full business days prior to the event.
  • No vouchers will be issued in lieu of a refund.
  • Transfers/substitute(s) are welcome (please notify us in advance of the program).
Ready to continue your professional development?
arrow-up icon